Colorectal Cancer Trial, Recruiting NCT07608120 Sponsor: Nanfang Hospital, Southern Medical University Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07608120
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 75 years of age who are already scheduled to have a planned (non-emergency) colonoscopy
  • People who have a standard medical reason for needing a colonoscopy
  • People who are able to understand and follow the bowel preparation instructions, including drinking a required amount of a laxative solution called polyethylene glycol (PEG)
  • People who are able to attend follow-up appointments and take part in data collection as required by the study
  • People who are willing and able to give written consent to participate

Who may not be able to join:

  • People who have previously been diagnosed with bowel cancer, a blocked bowel, or a suspected blocked bowel
  • People who are currently experiencing bleeding in their digestive system, or who have had confirmed digestive bleeding (such as black stools, blood in stools, or vomiting blood) in the past 4 weeks
  • People with serious kidney problems, severe heart failure, significant imbalances in body salts (electrolytes), or other health conditions that make the PEG bowel preparation unsuitable for them
  • People who have a known allergy to polyethylene glycol or to any ingredient in the electrolyte drink used in the study
  • People who are pregnant or breastfeeding
  • People whom the trial investigators consider unsuitable for the study for any other reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 13580317630

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanfang Hospital, Southern Medical University
Registry
ClinicalTrials.gov
Start date
18 May 2026
Est. completion
31 January 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Adequate Bowel Preparation Rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov